Today’s Solutions: December 19, 2025

The next time you tweak your back, think twice before heading to the medicine cabinet. Acetaminophen, best known as the active ingredient in Tylenol, is the most popular drug in the world for treating low back pain. But a new study shows that it doesn’t help any more than a placebo, or inert sugar pill, for getting rid of the pain.

Researchers in Australia divided over 1,600 people with low back pain into three groups: regular dosing with acetaminophen, as-needed dosing, and dosing with a placebo. In addition to measuring how long it took for the participants’ back pain to clear up, they also measured overall pain levels and participants’ ability to function, sleep, and their quality of life. Across the board, they saw no differences between the three groups—taking acetaminophen regularly or only when in pain had no effect on how the participants felt or how long they needed to recover.

These findings, published in the prestigious Lancet medical journal, undermine existing medical guidelines—which recommend acetaminophen as the first-choice drug for back pain.

(Source: The Lancet, 2014; DOI: 10.1016/S0140-6736(14)60805-9)

Print this article
More of Today's Solutions

New method uses sound waves to map soil health, stop famine, and restore farm...

BY THE OPTIMIST DAILY EDITORIAL TEAM Across the world, soil scientists are trading in their shovels for something unexpected: seismic sensors. In a breakthrough ...

Read More

This simple 15-minute mindset exercise can ease anxiety, science shows

BY THE OPTIMIST DAILY EDITORIAL TEAM A growing body of research is revealing how a short, simple activity that is done in just 15 ...

Read More

3 habits of the happiest people

Think of the happiest people you know. Do you find yourself often wondering what they are doing to maintain a general level of joy? ...

Read More

Changemakers of the week: GRuB and SparkNJ

Every day on the Optimist Daily, we report on solutions from around the world. Though we love solutions big and small, the ones that ...

Read More